Currently, the 2016 WHO classification of CNS tumors suggests the combined utilization of IDH1 status, 1p19q codeleted status, and histological subtypes to provide more objective diagnosis and classification of CNS tumors [8]. The gene discussed is IDH1; the disease is central nervous system neoplasm.